2,498
Participants
Start Date
May 31, 2009
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
Telmisartan (Kinzal/Pritor, BAY68-9291)
Patients treated with telmisartan tablets under the real-life setting. Dosing regimen customised to the needs of each participating patient according to the investigators assessment
Many Locations
Lead Sponsor
Bayer
INDUSTRY